Yuyoung Aspirin Enteric-Coated Tablet 100mg

Adult dose

Enteric-coated tablets: 1 tablet once daily, taken before meals with sufficient water. Enteric-coated capsules: 1 capsule once daily, taken before meals with sufficient water.

This medication may cause gastrointestinal bleeding if taken by individuals who regularly consume more than three glasses of alcohol daily; consult your doctor or pharmacist. This medication should not be administered to individuals with hypersensitivity to salicylates, history of peptic ulcer, aspirin asthma history, hemophilia, severe liver dysfunction, renal dysfunction, heart failure, bleeding tendencies, high-dose methotrexate users, and pregnant women in the third trimester. Patients with renal or liver problems, cardiovascular circulation dysfunction, blood disorders, bronchial asthma, those undergoing surgery, children under three years old, those with a history of allergies, elderly individuals, anticoagulant concurrent users, and those with glucose-6-phosphate dehydrogenase deficiency should use this medication with caution. While taking this medication, symptoms such as shock, anaphylaxis, hypersensitivity, skin rash, aplastic anemia, gastrointestinal bleeding, liver dysfunction, renal dysfunction, and neuropsychiatric symptoms may appear; if any unusual symptoms occur, discontinue use immediately and consult a healthcare professional. In children under 14 years with chickenpox or influenza, this medication should only be given cautiously when absolutely necessary, and their condition should be closely monitored due to the risk of Reye's syndrome. This medication is used for symptom relief, and regular blood tests and liver function tests are required with long-term use. The patient's condition should be carefully monitored after administration, especially in children or elderly individuals with high fever, or patients with wasting diseases. When treating infections, appropriate antibiotics should be used together while observing the infection status adequately. If this medication has been taken within one week before surgery, the risk of bleeding increases; therefore, inform the medical team when planning surgery. In case of overdose, symptoms of toxicity such as hallucinations, seizures, coma, and respiratory depression may occur, so caution is needed. This medication has antiplatelet aggregation inhibitory effects, which may increase the risk of bleeding; therefore, extreme caution should be exercised in patients with bleeding tendencies or those taking anticoagulants. Patients with gout should be cautious as this medication may reduce uric acid excretion and worsen symptoms. This medication may interact with several drugs; therefore, if other medications are being taken, it is essential to consult with a doctor or pharmacist. In the first and second trimesters of pregnancy, it should only be given at the minimum dose if necessary, and it should not be given in the third trimester as it poses risks to both the fetus and the mother. Breastfeeding women should avoid taking this medication as it can be passed into breast milk. Elderly individuals may experience adverse effects more easily, so treatment should begin with a small dose and should be carefully monitored. Enteric-coated formulations should be handled carefully to avoid damage to the coating and should not be taken with alkalis; they should be stored away from moisture.

Serious side effects

Hives, severe swelling (edema), shortness of breath, systemic flushing, angioedema, symptoms of anaphylaxis, asthma attack, Stevens-Johnson syndrome, Lyell syndrome (toxic epidermal necrolysis), exfoliative dermatitis, aplastic anemia, anemia, leukopenia, thrombocytopenia, impaired platelet function, hemolysis and hemolytic anemia, gastrointestinal bleeding, peptic ulcer and perforation, liver dysfunction, acute renal failure, severe edema, hypertension, severe headache, seizures, altered consciousness

Mild side effects

Erythema, itching, nasal congestion, cardiac-respiratory disorders, rash, swelling, symptoms of rhinitis, conjunctivitis, loss of appetite, heartburn, abdominal pain, nausea, vomiting, ringing in the ears, ear blockage, dizziness, headache, excitement, transient liver damage due to increased liver transaminases, hyperventilation, metabolic acidosis

Drug interactions

This medication may increase the risk of bleeding or decrease renal function when taken in conjunction with other non-steroidal anti-inflammatory drugs and salicylates. It should not be used with methotrexate at doses greater than 15mg/week. Certain non-steroidal anti-inflammatory drugs, anticoagulants, ibuprofen, naproxen, thrombolytics, antiplatelet agents, hemostatic agents, and diabetes treatments (insulin preparations, tolbutamide, etc.) may interact with this medication.

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It should also be stored in a cool place, maintaining a room temperature below 25 degrees Celsius is important.

Appearance

White, round enteric-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle